[1]PETTY WJ,PAZ-ARES L.Emerging strategies for the treatment of small cell lung cancer:A review [J].JAMA Oncology,2023,9(3):419-429.
[2]DESAI AP,ADASHEK JJ,REUSS JE,et al.Perioperative immune checkpoint inhibition in early-stage non-small cell lung cancer:A review [J].JAMA Oncology,2023,9(1):135-142.
[3]VITALE I,MANIC G,COUSSENS LM,et al.Macrophages and metabolism in the tumor microenvironment [J].Cell Metabolism,2019,30(1):36-50.
[4]TRAYHURN P.Hypoxia and adipose tissue function and dysfunction in obesity [J].Physiological Reviews,2013,93(1):1-21.
[5]DEBERARDINIS RJ,LUM JJ,HATZIVASSILIOU G,et al.The biology of cancer:metabolic reprogramming fuels cell growth and proliferation [J].Cell Metabolism,2008,7(1):11-20.
[6]RRINFELD BI,MADDEN MZ,WOLF MM,et al.Cell-programmed nutrient partitioning in the tumor microenvironment [J].Nature,2021,593(7858):282-288.
[7]NAKASHIMA R,GOTO Y,KOYASU S,et al.UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization [J].Scientific Reports,2017,7(1):6879.
[8]WILSON CL,MURPHY LB,LESLIE J,et al.Ubiquitin C-terminal hydrolase 1:A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease [J].Journal of Hepatology,2015,63(6):1421-1428.
[9]陈巍.肿瘤标志物检验在肺癌诊断中的临床价值分析[J].中国免疫学,2023,38(06):85-87.
CHEN W.Clinical value analysis of tumor marker testing in the diagnosis of lung cancer [J].Chinese Immunology,2023,38(06):85-87.
[10]LEI Q,YI T,LI H,et al.Ubiquitin C-terminal hydrolase L1 (UCHL1) regulates post-myocardial infarction cardiac fibrosis through glucose-regulated protein of 78 kDa (GRP78)[J].Scientific Reports,2020,10(1):10604.
[11]LAU S,PAN Y,VELCHETI V,et al.Squamous cell lung cancer:Current landscape and future therapeutic options [J].Cancer Cell,2022,40(11):1279-1293.
[12]LAHIRI A,MAJI A,POTDAR PD,et al.Lung cancer immunotherapy:progress,pitfalls,and promises [J].Molecular Cancer,2023,22(1):40.
[13]LI W,LIU JB,HOU LK,et al.Liquid biopsy in lung cancer:significance in diagnostics,prediction,and treatment monitoring[J].Molecular Cancer,2022,21(1):25.
[14]FRANK AR,LI V,SHELTON SD,et al.Mitochondrial-encoded complex I impairment induces a targetable dependency on aerobic fermentation in Hurthle cell carcinoma of the thyroid [J].Cancer Discovery,2023,32(12):27-32.
[15]LEE J,KIM K,KWON IC,et al.Intracellular glucose-depriving polymer micelles for antiglycolytic cancer treatment [J].Advanced Materials,2023,35(10):e2207342.
[16]FRESQUET V,GARCIA MJ,LARRAYOZ M,et al.Endogenous retroelement activation by epigenetic therapy reverses the Warburg effect and elicits mitochondrial-mediated cancer cell death [J].Cancer Discovery,2021,11(5):1268-1285.
[17]CAMERON AM,CASTOLDI A,SANIN DE,et al.Inflammatory macrophage dependence on NAD salvage is a consequence of reactive oxygen species-mediated DNA damage [J].Nature Immunology,2019,20(4):420-432.
[18]AGATHOCLE M,HARRIS WA.Metabolism in physiological cell proliferation and differentiation [J].Trends in Cell Biology,2013,23(10):484-492.
[19]ICARD P,SIMULA L,FOURNEL L,et al.The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer:Therapeutic implications [J].Drug Resistance Updates,2022,63(21):100852.
[20]GAO H,HARTNETT S,LI Y.Ubiquitin C-terminal hydrolase L1 regulates myoblast proliferation and differentiation [J].Biochemical and Biophysical Research Communications,2017,492(1):96-102.
[21]LI Y,LIH TM,DHANASEKARAN SM,et al.Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness [J].Cancer Cell,2023,41(1):139-163.
[22]TIAN C,LIU Y,LIU Y,et al.UCHL1 promotes cancer stemness in triple-negative breast cancer [J].Pathology,Research and Practice,2022,240(12):154235.